Cargando…
Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome
PURPOSE: Triglycerides are considered an emerging risk factor for cardiovascular mortality. Recent evidence relating depression and metabolic syndrome (MetS) implicated triglyceride levels. We thus investigated interrelations of self-reported depression severity (Zung) and MetS-related biological me...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390000/ https://www.ncbi.nlm.nih.gov/pubmed/28012071 http://dx.doi.org/10.1007/s40618-016-0601-y |
_version_ | 1782521369016139776 |
---|---|
author | Lemche, A. V. Chaban, O. S. Lemche, E. |
author_facet | Lemche, A. V. Chaban, O. S. Lemche, E. |
author_sort | Lemche, A. V. |
collection | PubMed |
description | PURPOSE: Triglycerides are considered an emerging risk factor for cardiovascular mortality. Recent evidence relating depression and metabolic syndrome (MetS) implicated triglyceride levels. We thus investigated interrelations of self-reported depression severity (Zung) and MetS-related biological measures with CVD risk estimates in MetS patients. METHODS: N = 101 patients fulfilling International Diabetes Federation criteria for MetS from a nationwide sampled treatment cohort for MetS with familial T2DM risk or manifest T2DM in a Ukrainian governmental health care system were participants. Both laboratory and non-laboratory measures were included. Recent European cardiological SCORE system CVD risk estimates were used as outcome variables. RESULTS: Following correlation matrix, we entered all variables into principal component analysis (PCA; 76.7% explained variance), followed by hierarchical regression and structural equation modeling (SEM). The PCA suggested a one-factor solution, where the latent variable showed highest loadings of SCORE risk estimates, triglycerides, depression severity, and pulse pressure. A comprehensive SEM was adjusted with 92.7% explained variance: overall CVD risk related to depression, pulse pressure, triglycerides, and fasting glucose. CONCLUSION: The findings in this MetS sample suggest that triglycerides and depression severity are the key variables among MetS biomarkers in cross-sectionally associating with the fatal and total SCORE risk estimates in MetS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40618-016-0601-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5390000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-53900002017-04-27 Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome Lemche, A. V. Chaban, O. S. Lemche, E. J Endocrinol Invest Original Article PURPOSE: Triglycerides are considered an emerging risk factor for cardiovascular mortality. Recent evidence relating depression and metabolic syndrome (MetS) implicated triglyceride levels. We thus investigated interrelations of self-reported depression severity (Zung) and MetS-related biological measures with CVD risk estimates in MetS patients. METHODS: N = 101 patients fulfilling International Diabetes Federation criteria for MetS from a nationwide sampled treatment cohort for MetS with familial T2DM risk or manifest T2DM in a Ukrainian governmental health care system were participants. Both laboratory and non-laboratory measures were included. Recent European cardiological SCORE system CVD risk estimates were used as outcome variables. RESULTS: Following correlation matrix, we entered all variables into principal component analysis (PCA; 76.7% explained variance), followed by hierarchical regression and structural equation modeling (SEM). The PCA suggested a one-factor solution, where the latent variable showed highest loadings of SCORE risk estimates, triglycerides, depression severity, and pulse pressure. A comprehensive SEM was adjusted with 92.7% explained variance: overall CVD risk related to depression, pulse pressure, triglycerides, and fasting glucose. CONCLUSION: The findings in this MetS sample suggest that triglycerides and depression severity are the key variables among MetS biomarkers in cross-sectionally associating with the fatal and total SCORE risk estimates in MetS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40618-016-0601-y) contains supplementary material, which is available to authorized users. Springer International Publishing 2016-12-23 2017 /pmc/articles/PMC5390000/ /pubmed/28012071 http://dx.doi.org/10.1007/s40618-016-0601-y Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Lemche, A. V. Chaban, O. S. Lemche, E. Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome |
title | Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome |
title_full | Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome |
title_fullStr | Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome |
title_full_unstemmed | Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome |
title_short | Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome |
title_sort | depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390000/ https://www.ncbi.nlm.nih.gov/pubmed/28012071 http://dx.doi.org/10.1007/s40618-016-0601-y |
work_keys_str_mv | AT lemcheav depressioncontributingtodyslipidemiccardiovascularriskinthemetabolicsyndrome AT chabanos depressioncontributingtodyslipidemiccardiovascularriskinthemetabolicsyndrome AT lemchee depressioncontributingtodyslipidemiccardiovascularriskinthemetabolicsyndrome |